Hera Biotech Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.74M
- Investors
-
11
Hera Biotech General Information
Description
Developer of definitive tissue-based tests designed to diagnose and stage endometriosis. The company's technology offers molecular testing, point-of-care cervical screening devices, and AI-powered tissue analysis tools, enabling clinicians, fertility centers, and research organizations to improve diagnostic accuracy and accelerate treatment decisions.
Contact Information
Website
www.herabiotech.comCorporate Office
- 4725 College Park
- Suite 200
- San Antonio, TX 78249
- United States
Corporate Office
- 4725 College Park
- Suite 200
- San Antonio, TX 78249
- United States
Hera Biotech Timeline
Hera Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 23-Sep-2026 | $1.74M | Completed | Startup | ||
| 9. Accelerator/Incubator | 01-Aug-2024 | Completed | Startup | |||
| 8. Early Stage VC (Series A) | 01-Jan-2024 | Completed | Startup | |||
| 7. Early Stage VC | 31-May-2023 | Completed | Startup | |||
| 6. Accelerator/Incubator | 01-Jan-2023 | Completed | Startup | |||
| 5. Early Stage VC (Series A) | Cancelled | Startup | ||||
| 4. Seed Round | 24-Aug-2022 | Completed | Startup | |||
| 3. Seed Round | 01-Aug-2021 | Completed | Startup | |||
| 2. Seed Round | 11-Sep-2020 | $175K | $175K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Hera Biotech Comparisons
Industry
Financing
Details
Hera Biotech Competitors (21)
One of Hera Biotech’s 21 competitors is Freenome, a Formerly VC-backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Freenome | Formerly VC-backed | Brisbane, CA | ||||
| ReproSource | Formerly VC-backed | Marlborough, MA | ||||
| Predicine | Venture Capital-Backed | Hayward, CA | ||||
| Advanced Cell Diagnostics | Formerly VC-backed | Minneapolis, MN | ||||
| Igenomix USA | Formerly PE-Backed | Paterna, Spain |
Hera Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hera Biotech Patents
Hera Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022483858-A1 | Biomarkers for the diagnosis of diseases or disorders of the female reproductive tract | Pending | 26-Oct-2022 | ||
| EP-4608992-A1 | Biomarkers for the diagnosis of diseases or disorders of the female reproductive tract | Inactive | 26-Oct-2022 | ||
| US-20260177561-A1 | Biomarkers for the diagnosis of diseases or disorders of the female reproductive tract | Pending | 26-Oct-2022 | ||
| EP-4423505-A1 | Jup biomarker for the diagnosis of diseases or disorders of the female reproductive tract | Pending | 26-Oct-2021 | G01N33/689 |
Hera Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hera Biotech Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cedars-Sinai Accelerator | Accelerator/Incubator | |||
| Portfolia | Venture Capital | Minority | ||
| Monday Capital | Venture Capital | Minority | ||
| Ignite Healthcare Network | Accelerator/Incubator | |||
| Althea Group (New York) | Venture Capital | Minority |
Hera Biotech Investments (1)
Hera Biotech’s most recent deal was a Later Stage VC with Scailyte for . The deal was made on 30-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Scailyte | 30-Jan-2024 | Later Stage VC | Drug Discovery |
Hera Biotech FAQs
-
When was Hera Biotech founded?
Hera Biotech was founded in 2020.
-
Where is Hera Biotech headquartered?
Hera Biotech is headquartered in San Antonio, TX.
-
What is the size of Hera Biotech?
Hera Biotech has 12 total employees.
-
What industry is Hera Biotech in?
Hera Biotech’s primary industry is Biotechnology.
-
Is Hera Biotech a private or public company?
Hera Biotech is a Private company.
-
What is Hera Biotech’s current revenue?
The current revenue for Hera Biotech is .
-
How much funding has Hera Biotech raised over time?
Hera Biotech has raised $6.03M.
-
Who are Hera Biotech’s investors?
Cedars-Sinai Accelerator, Portfolia, Monday Capital, Ignite Healthcare Network, and Althea Group (New York) are 5 of 11 investors who have invested in Hera Biotech.
-
Who are Hera Biotech’s competitors?
Freenome, ReproSource, Predicine, Advanced Cell Diagnostics, and Igenomix USA are some of the 21 competitors of Hera Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
